Results 151 to 160 of about 227,800 (324)
The Impact of Preeclampsia and Gestational Diabetes on Future Maternal Cardiometabolic Health
ABSTRACT Introduction Pregnancy is a time of significant maternal physiological change to meet the metabolic demands of the feto‐placental unit. In cases of pregnancy complications, mal‐adaptive physiological responses may occur, potentially impacting the health of both mother and fetus.
Alice M. Barrell +1 more
wiley +1 more source
Predisposing Factors for Coronary Vasospasm in Prinzmetal Angina - A Literature Review
Introduction and Purpose: Prinzmetal angina or vasospastic angina (VSA) is cardiac ischemia caused by spasm of the coronary arteries. It is characterized by chest pain at rest and ST-segment elevation on electrocardiographic (ECG).
Patrycja Znamirowska +9 more
doaj +1 more source
Cardiovascular Morbidity in Patients Undergoing Successful Surgery for Primary Hyperparathyroidism
ABSTRACT Objective Although previous studies have shown reduced cardiovascular events following parathyroidectomy (PTX), it is unclear whether this extends to contemporary patients diagnosed and treated with milder disease than previously. The aim of this nation‐wide study was to determine the effect on cardiovascular events after PTX, and to ...
Martin Nilsson +5 more
wiley +1 more source
Eccrine Coil Elastosis: A New Dermatopathological Feature Associated With Prediabetes and Diabetes
ABSTRACT Background The prevalence of diabetes mellitus continues to rise. Cutaneous histological manifestations of diabetes include microangiopathy and atherosclerosis. No morphological alterations of sweat glands have been reported. However, eccrine coil elastosis has been observed in basal cell carcinoma biopsies of a patient with metabolic syndrome,
Carlos Monteagudo +6 more
wiley +1 more source
Coronary angioplasty is a definitive, percutaneous intervention to improve myocardial oxygen supply. The benefit of coronary angioplasty for stable angina pectoris is still a controversy.
doaj +1 more source
Abstract Aims Chronic kidney disease (CKD) is a growing global health concern, and sodium‐glucose cotransporter 2 (SGLT2) inhibitors have emerged as a key treatment strategy. While their kidney‐protective effects are well established in both genders, women are prescribed these agents less frequently than men for the treatment of type 2 diabetes ...
Tatsuhiko Azegami +14 more
wiley +1 more source

